What is the ticker symbol for MyMD Pharmaceuticals?

MyMD Pharmaceuticals trades under the ticker MYMD on NASDAQ.

What sector does MyMD Pharmaceuticals operate in?

MyMD Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MYMD in a portfolio?

PortView shows MYMD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

MyMD Pharmaceuticals (MYMD) Stock Analysis

NASDAQHealthcareBiotechnology

$1.81-0.55%

1-year price historyRange $1.75 – $33.90

52-week range$1.81

$1.75$63.90

What MyMD Pharmaceuticals does

MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.

Key metrics

Market cap

$4.29M

P/E (TTM)

-0.20

EPS (TTM)

$-9.27

Beta

2.69

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.00

200-day avg

$5.24

52-week high

$63.90

52-week low

$1.75

CEO

Ian Rhodes CPA

ETFs linked to MYMD

Broad-market and Healthcare sector ETFs an investor holding MyMD Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how MYMD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MYMD in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for MyMD Pharmaceuticals?: MyMD Pharmaceuticals trades under the ticker MYMD on NASDAQ.
Which exchange is MYMD listed on?: MYMD is listed on NASDAQ.
What sector does MyMD Pharmaceuticals operate in?: MyMD Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MYMD in a portfolio?: PortView shows MYMD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.